Untreated gout progressively damages your joints, kidneys, and cardiovascular system. What starts as occasional painful flares in a single joint can evolve into a chronic condition with permanent bone erosion, visible deposits of uric acid crystals under your skin, and a significantly higher risk of kidney disease and heart-related death.
How Gout Progresses Without Treatment
Gout moves through distinct stages. The first attack typically hits the base of the big toe, though it can strike the ankle, knee, or wrist. That initial flare lasts a few hours to a few days and then resolves completely. You feel fine, and it’s tempting to assume it was a one-time event.
It isn’t. Between flares, uric acid crystals continue to accumulate silently in your joints. The underlying problem, a blood uric acid level above roughly 6.8 mg/dL (the concentration at which crystals begin to form in body fluids), doesn’t resolve on its own. Over months and years, flares become longer, more painful, and more frequent. They also begin affecting additional joints. The next most common sites after the big toe are the midfoot, ankles, knees, and arms. Eventually the pain-free gaps between attacks shrink until some people experience near-constant joint inflammation.
Bone Erosion and Permanent Joint Damage
Uric acid crystals don’t just trigger inflammation. They physically destroy bone through what researchers describe as an “outside-in” mechanism. Crystals first coat the surface of your cartilage and accumulate within the joint lining. From there, they interact with bone cells and gradually eat into the bone itself. Imaging studies confirm that in joints affected by gout, crystal deposits appear on the bone surface and within erosions, but never inside intact bone. The crystals work inward, not outward.
This erosion typically isn’t visible on standard X-rays until 5 to 10 years after the first gout attack. By the time damage shows up on imaging, significant structural harm has already occurred. The cartilage cushioning your joint thins and breaks down, and the underlying bone develops pits and defects that don’t heal on their own. In advanced cases, joints become visibly deformed and lose their range of motion.
Tophi: Visible Crystal Deposits
If left untreated, about one-third of gout patients develop tophi within five years. Tophi are firm, chalky lumps of crystallized uric acid that form under the skin and within tissues. They commonly appear on the fingers, toes, wrists, knees, the bony point of the elbow, the Achilles tendon, and the outer rim of the ear. In rare cases, they can form on the heart valves or in the eyes.
Tophi aren’t just cosmetic. They grow over time, pressing on surrounding tissue and bone. Large tophi can break through the skin, creating open wounds that drain a white, paste-like material and are prone to infection. They can also compress nerves, restrict tendon movement, and make it difficult or impossible to wear shoes, grip objects, or walk normally. Chronic tophaceous gout, the most advanced stage, typically develops after 10 or more years of recurrent attacks.
Kidney Damage and Kidney Stones
Your kidneys are responsible for filtering uric acid out of your blood, so they take a direct hit from chronic hyperuricemia. About 24% of people with gout have moderate to severe chronic kidney disease (stage 3 or higher). Population-level data shows that gout nearly doubles the risk of developing chronic kidney disease, with an adjusted hazard ratio of 1.78 compared to people without gout.
The relationship runs in both directions. High uric acid damages the kidneys, and damaged kidneys become less efficient at clearing uric acid, creating a worsening cycle. Uric acid crystals can also form directly in the kidneys, causing kidney stones. These stones are particularly common in people with persistently elevated uric acid levels and can cause severe flank pain, urinary blockages, and further kidney damage over time.
Cardiovascular Risks
Gout is an independent risk factor for dying from cardiovascular disease. A systematic review of large cohort studies found that people with gout face a 29% higher risk of cardiovascular death and a 42% higher risk of death from coronary heart disease, even after adjusting for traditional risk factors like high blood pressure, cholesterol, and smoking. The chronic, low-grade inflammation driven by uric acid crystal deposits throughout the body is thought to accelerate damage to blood vessels.
The comorbidity burden in people with gout is striking. Among those with significantly elevated uric acid levels, roughly two-thirds to three-quarters also have hypertension. About one-third have diabetes, and a similar proportion have heart failure. These conditions cluster together, and untreated gout appears to make each of them worse.
Higher Risk of Type 2 Diabetes
Chronically elevated uric acid disrupts how your body handles insulin, pushing you toward insulin resistance. A large retrospective study of nearly 90,000 people found that gout increases the risk of developing type 2 diabetes by 70% overall. The effect is even more pronounced in women, who face roughly double the diabetes risk compared to women without gout. Among the gout patients in this study, 13.2% developed type 2 diabetes during follow-up, compared to 10.6% of matched controls.
Elevated uric acid has been estimated to account for about 24% of the population-level risk of diabetes, making it one of the more significant modifiable predictors of the disease.
Loss of Mobility and Independence
At its most severe, untreated gout can become disabling. The U.S. Social Security Administration recognizes crystal deposition disorders, including gout, as a qualifying condition for disability benefits when they cause persistent inflammation or deformity in major joints. Qualifying impairments include needing a walker or bilateral canes, losing the ability to use an upper extremity for work tasks, or experiencing marked limitations in daily activities, social functioning, or the ability to concentrate and complete tasks on time.
This level of disability doesn’t happen overnight, but it is the logical endpoint of years of unchecked crystal accumulation and joint destruction. People with advanced gout may struggle to walk, dress themselves, or hold objects. The combination of joint deformity, tophaceous deposits, and chronic pain can fundamentally reshape daily life.
Reversibility Depends on Timing
The good news is that gout is one of the most treatable forms of arthritis when addressed early. Lowering blood uric acid below 6 mg/dL causes existing crystals to gradually dissolve. Studies confirm that patients who reach and maintain this target see crystals depleted from their joint fluid over time, which halts further erosion and prevents new flares. When tophi are already present, aiming for an even lower target of 4 to 5 mg/dL speeds up crystal dissolution.
The catch is that bone erosion, once it has occurred, doesn’t fully reverse. Cartilage that has been destroyed won’t regenerate. Tophi can shrink and disappear with sustained treatment, but the joint damage beneath them may be permanent. The difference between someone who starts treatment after their first flare and someone who waits a decade can be the difference between a normal life and permanent disability. Every year of untreated gout adds to the cumulative crystal burden and narrows the window for full recovery.